APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Respiratory Distress Syndrome

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.

Selected research

Market Structure

Global Respiratory Distress Syndrome Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173895400319 December 2025182 pages

Choose your research edition.

Industry ResearchRespiratory Distress Syndrome Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Respiratory Distress Syndrome Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Respiratory Distress Syndrome Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Respiratory Distress Syndrome Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Respiratory Distress Syndrome Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.

North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.

Report Includes

Read the full market overview

This report provides an overview of the global Respiratory Distress Syndrome market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Respiratory Distress Syndrome and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Respiratory Distress Syndrome revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Respiratory Distress Syndrome market size, projected growth trends, production technologies, key applications, and end-use industries.

Respiratory Distress Syndrome Segment by Company

Chiesi Farmaceutici

CR-Double Crane

ONY Biotech

AbbVie

Yuhan Corporation

JW Pharmaceuticals

Noargen

Respiratory Distress Syndrome Segment by Type

Poractant Alfa

Beractant

Calfactant

Others

Respiratory Distress Syndrome Segment by Application

Very Preterm Infants

Moderate to Late Preterm Infants

Others

Respiratory Distress Syndrome Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Respiratory Distress Syndrome market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Respiratory Distress Syndrome and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Respiratory Distress Syndrome.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Respiratory Distress Syndrome in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Respiratory Distress Syndrome industry.

Chapter 3: Detailed analysis of Respiratory Distress Syndrome companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Respiratory Distress Syndromerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Respiratory Distress Syndrome Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Poractant Alfa Table 3. Key Players of Beractant Table 4. Key Players of Calfactant Table 3. Key Players of Others Table 4. Global Respiratory Distress Syndrome Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Very Preterm Infants Table 6. Key Players of Moderate to Late Preterm Infants Table 7. Key Players of Others Table 8. Global Respiratory Distress Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Respiratory Distress Syndrome Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Respiratory Distress Syndrome Market Share by Region (2021-2026) Table 11. Global Respiratory Distress Syndrome Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Respiratory Distress Syndrome Market Share by Region (2027-2032) Table 13. Respiratory Distress Syndrome Industry Trends Table 14. Respiratory Distress Syndrome Industry Drivers Table 15. Respiratory Distress Syndrome Industry Opportunities and Challenges Table 16. Respiratory Distress Syndrome Industry Restraints Table 17. Global Respiratory Distress Syndrome Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Respiratory Distress Syndrome Revenue Market Share by Company (2021-2026) Table 19. Global Respiratory Distress Syndrome Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Respiratory Distress Syndrome Key Company Head Office and Area Served Table 21. Global Respiratory Distress Syndrome Company, Product Type & Application Table 22. Global Respiratory Distress Syndrome Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Respiratory Distress Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Respiratory Distress Syndrome Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Respiratory Distress Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Respiratory Distress Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Respiratory Distress Syndrome Revenue Market Share by Type (2021-2026) Table 29. Global Respiratory Distress Syndrome Revenue Market Share by Type (2027-2032) Table 30. Global Respiratory Distress Syndrome Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Respiratory Distress Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Respiratory Distress Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Respiratory Distress Syndrome Revenue Market Share by Application (2021-2026) Table 34. Global Respiratory Distress Syndrome Revenue Market Share by Application (2027-2032) Table 35. Chiesi Farmaceutici Company Information Table 36. Chiesi Farmaceutici Business Overview Table 37. Chiesi Farmaceutici Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Chiesi Farmaceutici Respiratory Distress Syndrome Product Portfolio Table 39. Chiesi Farmaceutici Recent Development Table 40. CR-Double Crane Company Information Table 41. CR-Double Crane Business Overview Table 42. CR-Double Crane Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. CR-Double Crane Respiratory Distress Syndrome Product Portfolio Table 44. CR-Double Crane Recent Development Table 45. ONY Biotech Company Information Table 46. ONY Biotech Business Overview Table 47. ONY Biotech Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. ONY Biotech Respiratory Distress Syndrome Product Portfolio Table 49. ONY Biotech Recent Development Table 50. AbbVie Company Information Table 51. AbbVie Business Overview Table 52. AbbVie Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. AbbVie Respiratory Distress Syndrome Product Portfolio Table 54. AbbVie Recent Development Table 55. Yuhan Corporation Company Information Table 56. Yuhan Corporation Business Overview Table 57. Yuhan Corporation Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Yuhan Corporation Respiratory Distress Syndrome Product Portfolio Table 59. Yuhan Corporation Recent Development Table 60. JW Pharmaceuticals Company Information Table 61. JW Pharmaceuticals Business Overview Table 62. JW Pharmaceuticals Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. JW Pharmaceuticals Respiratory Distress Syndrome Product Portfolio Table 64. JW Pharmaceuticals Recent Development Table 65. Noargen Company Information Table 66. Noargen Business Overview Table 67. Noargen Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Noargen Respiratory Distress Syndrome Product Portfolio Table 69. Noargen Recent Development Table 70. North America Respiratory Distress Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 71. North America Respiratory Distress Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 72. North America Respiratory Distress Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 73. North America Respiratory Distress Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 74. North America Respiratory Distress Syndrome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Respiratory Distress Syndrome Market Size by Country (2021-2026) Table 76. North America Respiratory Distress Syndrome Market Size by Country (2027-2032) Table 77. Europe Respiratory Distress Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 78. Europe Respiratory Distress Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 79. Europe Respiratory Distress Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 80. Europe Respiratory Distress Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 81. Europe Respiratory Distress Syndrome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Respiratory Distress Syndrome Market Size by Country (2021-2026) Table 83. Europe Respiratory Distress Syndrome Market Size by Country (2027-2032) Table 84. China Respiratory Distress Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 85. China Respiratory Distress Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 86. China Respiratory Distress Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 87. China Respiratory Distress Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 88. Asia Respiratory Distress Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 89. Asia Respiratory Distress Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 90. Asia Respiratory Distress Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 91. Asia Respiratory Distress Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 92. Asia Respiratory Distress Syndrome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Respiratory Distress Syndrome Market Size by Country (2021-2026) Table 94. Asia Respiratory Distress Syndrome Market Size by Country (2027-2032) Table 95. South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2021-2026) & (US$ Million) Table 96. South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2027-2032) & (US$ Million) Table 97. South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2021-2026) & (US$ Million) Table 98. South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2027-2032) & (US$ Million) Table 99. South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2021-2026) Table 101. South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Respiratory Distress Syndrome Product Image Figure 2. Global Respiratory Distress Syndrome Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Respiratory Distress Syndrome Market Share by Type: 2025 VS 2032 Figure 4. Poractant Alfa Image Figure 5. Beractant Image Figure 6. Calfactant Image Figure 7. Others Image Figure 8. Global Respiratory Distress Syndrome Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Respiratory Distress Syndrome Market Share by Application: 2025 VS 2032 Figure 10. Very Preterm Infants Image Figure 11. Moderate to Late Preterm Infants Image Figure 12. Others Image Figure 13. Global Respiratory Distress Syndrome Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 15. Global Respiratory Distress Syndrome Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Respiratory Distress Syndrome Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Respiratory Distress Syndrome Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Respiratory Distress Syndrome Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Respiratory Distress Syndrome Revenue Market Share by Type (2021-2032) Figure 22. Global Respiratory Distress Syndrome Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Respiratory Distress Syndrome Revenue Market Share by Application (2021-2032) Figure 24. North America Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 25. North America Respiratory Distress Syndrome Market Share by Type (2021-2032) Figure 26. North America Respiratory Distress Syndrome Market Share by Application (2021-2032) Figure 27. North America Respiratory Distress Syndrome Market Share by Country (2021-2032) Figure 28. United States Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 29. Canada Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 31. Europe Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 32. Europe Respiratory Distress Syndrome Market Share by Type (2021-2032) Figure 33. Europe Respiratory Distress Syndrome Market Share by Application (2021-2032) Figure 34. Europe Respiratory Distress Syndrome Market Share by Country (2021-2032) Figure 35. Germany Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 36. France Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 38. Italy Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 39. Russia Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 41. China Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 42. China Respiratory Distress Syndrome Market Share by Type (2021-2032) Figure 43. China Respiratory Distress Syndrome Market Share by Application (2021-2032) Figure 44. Asia Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 45. Asia Respiratory Distress Syndrome Market Share by Type (2021-2032) Figure 46. Asia Respiratory Distress Syndrome Market Share by Application (2021-2032) Figure 47. Asia Respiratory Distress Syndrome Market Share by Country (2021-2032) Figure 48. Japan Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 52. India Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 53. Australia Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Respiratory Distress Syndrome Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Respiratory Distress Syndrome Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Respiratory Distress Syndrome Market Share by Country (2021-2032) Figure 58. Brazil Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 63. UAE Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 65. Chile Respiratory Distress Syndrome Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Poractant Alfa
  • Beractant
  • Calfactant
  • Others
Applications
  • Very Preterm Infants
  • Moderate to Late Preterm Infants
  • Others
Companies covered
  • Chiesi Farmaceutici
  • CR-Double Crane
  • ONY Biotech
  • AbbVie
  • Yuhan Corporation
  • JW Pharmaceuticals
  • Noargen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Poractant Alfa
  5. 1.2.3 Beractant
  6. 1.2.4 Calfactant
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Very Preterm Infants
  11. 1.3.3 Moderate to Late Preterm Infants
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Respiratory Distress Syndrome Growth Trends by Region
  15. 1.5.1 Global Respiratory Distress Syndrome Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Respiratory Distress Syndrome Market Size by Region (2021-2026)
  17. 1.5.3 Respiratory Distress Syndrome Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Respiratory Distress Syndrome Market Dynamics
  1. 2.1 Respiratory Distress Syndrome Industry Trends
  2. 2.2 Respiratory Distress Syndrome Industry Drivers
  3. 2.3 Respiratory Distress Syndrome Industry Opportunities and Challenges
  4. 2.4 Respiratory Distress Syndrome Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Respiratory Distress Syndrome Revenue by Company (2021-2026)
  2. 3.2 Global Respiratory Distress Syndrome Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Respiratory Distress Syndrome Key Company Head office and Area Served
  4. 3.4 Global Respiratory Distress Syndrome Company, Product Type & Application
  5. 3.5 Global Respiratory Distress Syndrome Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Respiratory Distress Syndrome Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Respiratory Distress Syndrome Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Respiratory Distress Syndrome Tier 1, Tier 2, and Tier 3
4 Respiratory Distress Syndrome Market by Type
  1. 4.1 Global Respiratory Distress Syndrome Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Respiratory Distress Syndrome Market Size by Type (2021-2032)
  3. 4.3 Global Respiratory Distress Syndrome Market Size Share by Type (2021-2032)
5 Respiratory Distress Syndrome Market by Application
  1. 5.1 Global Respiratory Distress Syndrome Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Respiratory Distress Syndrome Market Size by Application (2021-2032)
  3. 5.3 Global Respiratory Distress Syndrome Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Chiesi Farmaceutici
  2. 6.1.1 Chiesi Farmaceutici Company Information
  3. 6.1.2 Chiesi Farmaceutici Business Overview
  4. 6.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Chiesi Farmaceutici Respiratory Distress Syndrome Product Portfolio
  6. 6.1.5 Chiesi Farmaceutici Recent Developments
  7. 6.2 CR-Double Crane
  8. 6.2.1 CR-Double Crane Company Information
  9. 6.2.2 CR-Double Crane Business Overview
  10. 6.2.3 CR-Double Crane Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 CR-Double Crane Respiratory Distress Syndrome Product Portfolio
  12. 6.2.5 CR-Double Crane Recent Developments
  13. 6.3 ONY Biotech
  14. 6.3.1 ONY Biotech Company Information
  15. 6.3.2 ONY Biotech Business Overview
  16. 6.3.3 ONY Biotech Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 ONY Biotech Respiratory Distress Syndrome Product Portfolio
  18. 6.3.5 ONY Biotech Recent Developments
  19. 6.4 AbbVie
  20. 6.4.1 AbbVie Company Information
  21. 6.4.2 AbbVie Business Overview
  22. 6.4.3 AbbVie Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AbbVie Respiratory Distress Syndrome Product Portfolio
  24. 6.4.5 AbbVie Recent Developments
  25. 6.5 Yuhan Corporation
  26. 6.5.1 Yuhan Corporation Company Information
  27. 6.5.2 Yuhan Corporation Business Overview
  28. 6.5.3 Yuhan Corporation Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Yuhan Corporation Respiratory Distress Syndrome Product Portfolio
  30. 6.5.5 Yuhan Corporation Recent Developments
  31. 6.6 JW Pharmaceuticals
  32. 6.6.1 JW Pharmaceuticals Company Information
  33. 6.6.2 JW Pharmaceuticals Business Overview
  34. 6.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 JW Pharmaceuticals Respiratory Distress Syndrome Product Portfolio
  36. 6.6.5 JW Pharmaceuticals Recent Developments
  37. 6.7 Noargen
  38. 6.7.1 Noargen Company Information
  39. 6.7.2 Noargen Business Overview
  40. 6.7.3 Noargen Respiratory Distress Syndrome Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Noargen Respiratory Distress Syndrome Product Portfolio
  42. 6.7.5 Noargen Recent Developments
7 North America
  1. 7.1 North America Respiratory Distress Syndrome Market Size (2021-2032)
  2. 7.2 North America Respiratory Distress Syndrome Market Size by Type
  3. 7.2.1 North America Respiratory Distress Syndrome Market Size by Type (2021-2026)
  4. 7.2.2 North America Respiratory Distress Syndrome Market Size by Type (2027-2032)
  5. 7.2.3 North America Respiratory Distress Syndrome Market Share by Type (2021-2032)
  6. 7.3 North America Respiratory Distress Syndrome Market Size by Application
  7. 7.3.1 North America Respiratory Distress Syndrome Market Size by Application (2021-2026)
  8. 7.3.2 North America Respiratory Distress Syndrome Market Size by Application (2027-2032)
  9. 7.3.3 North America Respiratory Distress Syndrome Market Share by Application (2021-2032)
  10. 7.4 North America Respiratory Distress Syndrome Market Size by Country
  11. 7.4.1 North America Respiratory Distress Syndrome Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Respiratory Distress Syndrome Market Size by Country (2021-2026)
  13. 7.4.3 North America Respiratory Distress Syndrome Market Size by Country (2027-2032)
  14. 7.4.4 North America Respiratory Distress Syndrome Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Respiratory Distress Syndrome Market Size (2021-2032)
  2. 8.2 Europe Respiratory Distress Syndrome Market Size by Type
  3. 8.2.1 Europe Respiratory Distress Syndrome Market Size by Type (2021-2026)
  4. 8.2.2 Europe Respiratory Distress Syndrome Market Size by Type (2027-2032)
  5. 8.2.3 Europe Respiratory Distress Syndrome Market Share by Type (2021-2032)
  6. 8.3 Europe Respiratory Distress Syndrome Market Size by Application
  7. 8.3.1 Europe Respiratory Distress Syndrome Market Size by Application (2021-2026)
  8. 8.3.2 Europe Respiratory Distress Syndrome Market Size by Application (2027-2032)
  9. 8.3.3 Europe Respiratory Distress Syndrome Market Share by Application (2021-2032)
  10. 8.4 Europe Respiratory Distress Syndrome Market Size by Country
  11. 8.4.1 Europe Respiratory Distress Syndrome Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Respiratory Distress Syndrome Market Size by Country (2021-2026)
  13. 8.4.3 Europe Respiratory Distress Syndrome Market Size by Country (2027-2032)
  14. 8.4.4 Europe Respiratory Distress Syndrome Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Respiratory Distress Syndrome Market Size (2021-2032)
  2. 9.2 China Respiratory Distress Syndrome Market Size by Type
  3. 9.2.1 China Respiratory Distress Syndrome Market Size by Type (2021-2026)
  4. 9.2.2 China Respiratory Distress Syndrome Market Size by Type (2027-2032)
  5. 9.2.3 China Respiratory Distress Syndrome Market Share by Type (2021-2032)
  6. 9.3 China Respiratory Distress Syndrome Market Size by Application
  7. 9.3.1 China Respiratory Distress Syndrome Market Size by Application (2021-2026)
  8. 9.3.2 China Respiratory Distress Syndrome Market Size by Application (2027-2032)
  9. 9.3.3 China Respiratory Distress Syndrome Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Respiratory Distress Syndrome Market Size (2021-2032)
  2. 10.2 Asia Respiratory Distress Syndrome Market Size by Type
  3. 10.2.1 Asia Respiratory Distress Syndrome Market Size by Type (2021-2026)
  4. 10.2.2 Asia Respiratory Distress Syndrome Market Size by Type (2027-2032)
  5. 10.2.3 Asia Respiratory Distress Syndrome Market Share by Type (2021-2032)
  6. 10.3 Asia Respiratory Distress Syndrome Market Size by Application
  7. 10.3.1 Asia Respiratory Distress Syndrome Market Size by Application (2021-2026)
  8. 10.3.2 Asia Respiratory Distress Syndrome Market Size by Application (2027-2032)
  9. 10.3.3 Asia Respiratory Distress Syndrome Market Share by Application (2021-2032)
  10. 10.4 Asia Respiratory Distress Syndrome Market Size by Country
  11. 10.4.1 Asia Respiratory Distress Syndrome Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Respiratory Distress Syndrome Market Size by Country (2021-2026)
  13. 10.4.3 Asia Respiratory Distress Syndrome Market Size by Country (2027-2032)
  14. 10.4.4 Asia Respiratory Distress Syndrome Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Respiratory Distress Syndrome Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Respiratory Distress Syndrome Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Respiratory Distress Syndrome Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Respiratory Distress Syndrome Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Respiratory Distress Syndrome Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst